Literature DB >> 9266259

Granulocyte colony-stimulating factor (G-CSF) serum levels in surgical intensive care patients.

W Gross-Weege1, K Dumon, A Dahmen, E M Schneider, H D Röher.   

Abstract

The granulocyte colony-stimulating factor (G-CSF) regulates neutrophil differentiation and function. Serum levels of G-CSF increase during acute infectious processes. The levels of G-CSF were measured in 59 surgical intensive care unit (ICU) patients. In general, G-CSF was only elevated during the first 2 days after admission to the ICU. Higher G-CSF levels were more frequently observed in patients without infectious complications and in patients who survived. Later on, G-CSF levels were below 100 pg/ml in almost all patients studied. The highest G-CSF level (20,000 pg/ml) was observed in one patient with septic shock 36 h after leukopenia. The patient recovered from septic shock and multiple organ failure and was discharged. It is proposed that surgical ICU patients with low or undetectable G-CSF serum levels may benefit from exogenous G-CSF substitution protocols.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266259     DOI: 10.1007/bf01713146

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  17 in total

Review 1.  Granulocyte colony-stimulating factor and its receptor.

Authors:  G D Demetri; J D Griffin
Journal:  Blood       Date:  1991-12-01       Impact factor: 22.113

Review 2.  Recombinant methionyl granulocyte colony-stimulating factor (filgrastim): a new dimension in immunotherapy.

Authors:  G Schwab; T Hecht
Journal:  Ann Hematol       Date:  1994-07       Impact factor: 3.673

Review 3.  Measurement and clinical significance of circulating hematopoietic growth factor levels.

Authors:  J Cebon; J Layton
Journal:  Curr Opin Hematol       Date:  1994-05       Impact factor: 3.284

4.  CDC definitions for nosocomial infections, 1988.

Authors:  J S Garner; W R Jarvis; T G Emori; T C Horan; J M Hughes
Journal:  Am J Infect Control       Date:  1988-06       Impact factor: 2.918

5.  Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils.

Authors:  E Roilides; T J Walsh; P A Pizzo; M Rubin
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

6.  Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha.

Authors:  I Görgen; T Hartung; M Leist; M Niehörster; G Tiegs; S Uhlig; F Weitzel; A Wendel
Journal:  J Immunol       Date:  1992-08-01       Impact factor: 5.422

Review 7.  Role of granulocyte colony-stimulating factor in the immune response to acute bacterial infection in the nonneutropenic host: an overview.

Authors:  S Nelson
Journal:  Clin Infect Dis       Date:  1994-02       Impact factor: 9.079

8.  Enhancement of neutrophil function by in vivo filgrastim treatment for prophylaxis of sepsis in surgical intensive care patients.

Authors:  M Weiss; W Gross-Weege; M Schneider; H Neidhardt; S Liebert; N Mirow; P Wernet
Journal:  J Crit Care       Date:  1995-03       Impact factor: 3.425

9.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.

Authors:  J L Vincent; D J Bihari; P M Suter; H A Bruining; J White; M H Nicolas-Chanoin; M Wolff; R C Spencer; M Hemmer
Journal:  JAMA       Date:  1995 Aug 23-30       Impact factor: 56.272

10.  Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans.

Authors:  D B Kuhns; W G Alvord; J I Gallin
Journal:  J Infect Dis       Date:  1995-01       Impact factor: 5.226

View more
  6 in total

1.  Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection.

Authors:  F de Lalla; G Pellizzer; M Strazzabosco; Z Martini; G Du Jardin; L Lora; P Fabris; P Benedetti; G Erle
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

2.  Granulocyte colony-stimulating factor mobilizes dormant hematopoietic stem cells without proliferation in mice.

Authors:  Jeffrey M Bernitz; Michael G Daniel; Yesai S Fstkchyan; Kateri Moore
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

3.  Bactericidal activity response of blood neutrophils from critically ill patients to in vitro granulocyte colony-stimulating factor stimulation.

Authors:  Kun Yang; Elie Azoulay; Lynda Attalah; Jean-Ralph Zahar; Andry Van de Louw; Charles Cerf; Claude-James Soussy; Philippe Duvaldestin; Laurent Brochard; Christian Brun-Buisson; Alain Harf; Christophe Delclaux
Journal:  Intensive Care Med       Date:  2003-01-23       Impact factor: 17.440

4.  Regulation of hematopoietic stem cell activity by inflammation.

Authors:  Laura G Schuettpelz; Daniel C Link
Journal:  Front Immunol       Date:  2013-07-19       Impact factor: 7.561

5.  Assessing the Impact of Cyclosporin A on Lentiviral Transduction and Preservation of Human Hematopoietic Stem Cells in Clinically Relevant Ex Vivo Gene Therapy Settings.

Authors:  Carolina Petrillo; Andrea Calabria; Francesco Piras; Alessia Capotondo; Giulio Spinozzi; Ivan Cuccovillo; Fabrizio Benedicenti; Luigi Naldini; Eugenio Montini; Alessandra Biffi; Bernhard Gentner; Anna Kajaste-Rudnitski
Journal:  Hum Gene Ther       Date:  2019-05-24       Impact factor: 5.695

6.  G-CSF regulates hematopoietic stem cell activity, in part, through activation of Toll-like receptor signaling.

Authors:  L G Schuettpelz; J N Borgerding; M J Christopher; P K Gopalan; M P Romine; A C Herman; J R Woloszynek; A M Greenbaum; D C Link
Journal:  Leukemia       Date:  2014-02-12       Impact factor: 11.528

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.